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Abstract
During infection, pneumococci exist mainly in sessile biofilms rather than in planktonic form, except during sepsis. However,
relatively little is known about how biofilms contribute to pneumococcal pathogenesis. Here, we carried out a biofilm assay
on opaque and transparent variants of a clinical serotype 19F strain WCH159. After 4 days incubation, scanning electron
microscopy revealed that opaque biofilm bacteria produced an extracellular matrix, whereas the transparent variant did not.
The opaque biofilm-derived bacteria translocated from the nasopharynx to the lungs and brain of mice, and showed 100-
fold greater in vitro adherence to A549 cells than transparent bacteria. Microarray analysis of planktonic and sessile bacteria
from transparent and opaque variants showed differential gene expression in two operons: the lic operon, which is involved
in choline uptake, and in the two-component system, ciaRH. Mutants of these genes did not form an extracellular matrix,
could not translocate from the nasopharynx to the lungs or the brain, and adhered poorly to A549 cells. We conclude that
only the opaque phenotype is able to form extracellular matrix, and that the lic operon and ciaRH contribute to this process.
We propose that during infection, extracellular matrix formation enhances the ability of pneumococci to cause invasive
disease.
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Introduction
Asymptomatic colonization of the upper respiratory tract is the
first step in the pathogenesis of infection for most bacteria that
cause pneumonia, otitis media (OM) and meningitis [1,2]. These
infections are related to biofilm-like diseases, and more than 60%
of bacterial infections are considered to involve microbial growth
in biofilms. Indeed, direct detection of biofilms in the nasopha-
ryngeal cavity, in the middle ear mucosa of children with recurrent
or chronic OM, and in animal studies, or indirect detection in
pneumonia and meningitis, has been demonstrated [3,4,5,6,7,8].
A biofilm has been defined as a ‘‘microbially derived sessile
community characterized by cells that are irreversibly attached to
a substratum or interface or to each other, are embedded in a
matrix of extracellular polymeric substances that they have
produced, and exhibit an altered phenotype with respect to
growth rate and gene transcription’’ [9]. This growth character-
istic protects bacteria from many environmental challenges,
including antibiotic therapy and host immune defences. Thus,
the study of bacteria in biofilm communities will increase our
understanding of bacterial pathogenesis and can aid in the
development of alternative prophylactic and/or therapeutic
strategies.
Streptococcus pneumoniae (the pneumococcus) is the predominant
pathogen detected in OM cases, followed by Moraxella catarrhalis
and non-typable Haemophilus influenzae, respectively [10]. In
addition to being responsible for other local infections like
conjunctivitis and sinusitis, the pneumococcus is the predominant
cause of community-acquired pneumonia [11]. It is responsible for
1 to 2 million deaths in children under the age of five worldwide,
despite the availability of multiple antimicrobials and different
vaccine formulations [12,13]. Pneumococci are also able to
undergo spontaneous bi-directional phase variation between two
distinct colonial morphologies, described as opaque and transpar-
ent. The transparent phenotype exhibits increased in vitro
adherence relative to opaque variants of the same strain, as well
as an enhanced capacity to colonize the nasopharynx of infant rats
[14]. On the other hand, the opaque form is associated with
massively increased virulence in animal models of systemic disease,
and this correlates with increased production of capsular
polysaccharide relative to cell wall teichoic acid, as well as
pneumococcal surface protein A (PspA), compared with the
transparent phenotype [14,15,16]. However, to date, the genetic
and/or biochemical basis of pneumococcal opacity is yet to be
clearly determined. Furthermore, the literature is not clear as to
the relevance of the two opacity variants in invasive disease. For
instance, the ability to colonize the nasal cavity of infected infant
rats was shown to be a predominant characteristic of the
transparent phenotype, while no difference was observed in
virulence following intraperitoneal injection of either the trans-
parent or opaque phenotype [14]. However, it was later shown
that following intraperitoneal infection of adult mice, the opaque
phenotype was significantly more virulent than the transparent
counterpart [15]. The ability of the two variants to colonize was
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19844also tested using a chinchilla model and no difference was
observed unless there was a prior challenge with influenza A virus
[17]. Finally, it is proposed that the greater recovery of transparent
pneumococci from the nasal mucosa of mice is due to their
propensity to detach more easily [16].
In addition to colony opacity variants, many other pneumo-
coccal factors have been implicated in colonization and invasive
disease [18,19]. The requirement for capsular polysaccharide
(CPS) for colonization was demonstrated in a mouse model by
showing that unencapsulated mutants were still able to persist in
the nasal cavity, but at a reduced density and duration compared
to their encapsulated parent strains [20,21]. In contrast,
unencapsulated strains have been reported to adhere better in
vitro relative to their encapsulated counterparts [22,23] Therefore,
the relationship between opaque vs transparent phenotype,
encapsulation, colonization and biofilm formation are still unclear,
and presents an attractive avenue for further study.
While a large body of work has been published on character-
istics of biofilm formation in other pathogenic bacteria such as
Pseudomonas aeruginosa [24,25] and H. influenzae [26,27], relatively
little is known about the characteristics of pneumococcal biofilms
and how this impacts on pathogenesis of disease [28,29,30,31].
Given that biofilm formation appears to be the primary mode of
pneumococcal growth during the early stages of colonization and
invasion, we examined the microscopic architecture of static
biofilms formed by a range of clinical isolates starting from pure
cultures of opaque and transparent phase variants. The virulence
traits of bacteria derived from biofilms formed by transparent and
opaque variants were investigated in a mouse intranasal infection
model, as was in vitro adherence to A549 and Detroit 562 cell lines.
The molecular basis for the phenotypic differences was also
investigated by microarray analysis of sessile versus planktonic
opaque and transparent variants, and the role of candidate
biofilm-associated genes in pathogenesis was evaluated in a mouse
infection model.
Results
Biofilm formation by mixed pneumococcal cultures
A number of S. pneumoniae isolates belonging to different
serotypes were tested for the ability to form biofilms in a static
model in Todd-Hewitt medium supplemented with 0.5% yeast
extract (THY). After 24 h incubation, the number of bacteria
harvested from sessile cultures was similar for all the strains tested
(Fig. 1A), ranging between approximately 2610
4 to 2610
6 CFU/
well. At 3 days post-incubation, a decrease in numbers of sessile
bacteria was observed for all strains, probably because the
bacterial biofilm was in the dispersal stage. However, by day 4,
the strains could be split into two groups and an increase in the
number of adherent bacteria was observed. This is consistent with
a previous study which describes the formation of new biofilm
colonies through detachment [9]. The two type 19F strains
(WCH158 and WCH159) and the reference strain D39 were able
to reach the same density observed at 24 h at days 4 and 5.
However, WCH16, WCH43 and WCH132 were still attached to
the surfaces as confirmed by enumeration of bacteria, but with
1000-fold lower counts (P=0.005 and P=0.002 at days 4 and 5,
respectively). Colony morphology analysis of the cultures on THY-
catalase plates showed a higher percentage of transparent variants
in the low biofilm-forming strains (WCH16, WCH43 and
WCH132), whereas the opposite was the case for the high biofilm
forming strains (WCH158, WCH159 and D39). Over time, the
transparent variants predominated in low biofilm forming strains,
reaching almost 90% at day 4. On the contrary, for high biofilm
forming strains, the proportion of transparent variants was always
below 50%, and by day 7 the percentage of the opaque variants
was almost 90% (Figure S1).
Scanning electron microscopy (SEM) was used to observe the
nature of pneumococcal biofilm formation by bacteria grown on
coverslips. Sessile and planktonic samples were collected at 4 days
post-incubation where the bacterial numbers were higher and
when more complex attached microbial communities could be
observed. In the high biofilm-forming strains, sessile bacteria were
completely embedded in an extracellular matrix (Fig. 1 B–G),
whereas the opposite was the scenario for the low biofilm-forming
strains. In the latter, the presence of matrix was observed only in
planktonic, but not in sessile bacteria (Fig. 2A). The high
percentage of transparent bacteria in those samples could lead to
easy detachment, because it is likely that the matrix produced by
those bacteria was not in sufficient quantity to allow attachment to
the substratum. Taken together, these data demonstrate that
different pneumococcal strains exhibit distinct biofilm character-
istics, and that a link exists between transparent/opaque
phenotype and low or high biofilm formation.
Biofilm formation by opaque and transparent
phenotypes and SEM analysis
We observed that strains harvested from static biofilm models
showed a clear preference to remain attached to the substratum if
the bacterial population was predominantly of the opaque
phenotype, whereas the opposite was true if transparent variants
were more abundant. Therefore, to investigate the role of the
opaque and transparent phenotypes in biofilm formation, pure
transparent and opaque colony variants were used and selected as
described in Experimental procedures. In the opaque variants, all
strains tested were able to form biofilms up to day 7, and no
obvious differences were observed over the incubation period.
However, the transparent variants of D39, WCH16 and WCH43
were unable to attach to the plastic support, and by day 4, no
sessile bacteria were detected (Figure S2). The presence of opaque
variants seems to be essential, at least for some serotypes, to permit
prolonged adherence onto the plastic substratum. Given the fact
that competence has been shown to be involved in the biofilm
process [32], CSP-induced competence levels of opacity variants of
the six strains used in this study was determined. In all serotypes
tested, the transparent variant was more capable of taking up
external DNA compared to its opaque counterpart (data not
shown). Thus, it appears that the increased ability of opaque
variants to form biofilms is not due to increased competence with
respect to transparent variants.
SEM analysis of strains showed cells embedded completely in an
extracellular matrix in the case of sessile samples collected from the
opaque variant (Fig. 3A), whereas for sessile samples generated by
the transparent variants, only matrix-free bacteria were observed
(Fig. 3B). These analyses clearly show a positive correlation
between opaque colony morphology and matrix formation.
Therefore, sessile bacteria can be subdivided into two morpho-
logical types: those that are able to attach (i.e. form biofilms) but
do not produce extracellular matrix, and those form biofilms as
well as produce extracellular matrix. We also observed that strain
WCH159 was able to form a biofilm from both transparent and
opaque variants and showed the most stable phenotypes when
comparing different experimental data sets. Therefore, subsequent
studies were performed primarily using WCH159.
Mouse infection model
A correlation between in vitro biofilm formation and in vivo
infection is already well described [6,32,33]. In the current study,
Biofilm Matrix Aids Invasive Pneumococcal Disease
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e19844Biofilm Matrix Aids Invasive Pneumococcal Disease
PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e19844we demonstrated the ability of opaque variants to form an
extracellular matrix on plastic supports. We then used a mouse
intranasal (i.n.) infection model to investigate the significance of
matrix formation in vivo. For this purpose, CD1 mice were infected
i.n. under anesthesia with approximately 5610
6 CFU of pneu-
mococci either detached from the surface of microtiter wells or
taken from the liquid phase of the culture. At 24, 48 and 96 h post-
infection, mice were euthanazed (none of the mice succumbed to
infection during this time period) and bacteria from the
nasopharynx, lungs, blood and brain of each mouse were
enumerated by plating on blood agar, and on THY-catalase
plates to verify colony phenotype. As shown in Fig. 4, at 24 h, no
difference in bacterial numbers recovered from the nasopharynx
was observed between groups of mice infected with sessile or
planktonic transparent pneumococci. However, significantly fewer
bacteria were recovered from the nasopharynx of mice infected
with the planktonic opaque pneumococci with respect to sessile
and planktonic transparent pneumococci (P=0.03). At all time
points, there was no detectable bacteremia, and, with the single
exception of mice infected with planktonic transparent pneumo-
cocci, no bacteria in the brain at 24 h. The situation observed in
the nasopharynx at 48 h was almost the same as at 24 h, except
that some bacteria had translocated to the lungs of mice infected
with sessile opaque bacteria. At day 4 post-infection, the situation
was completely different. Mice infected with sessile opaque
pneumococci had bacteria in the lungs, whereas not detectable
number of pneumococci could be recovered from mice infected
with other phenotypic variants (P=0.0002). In the brain, 4 out of
9 mice challenged with sessile opaque bacteria had between 10
2–
10
3 CFU, although this did not reach statistical significance
(Fig. 4). Colony morphology analysis of bacteria recovered from
the lungs and brain of mice revealed the presence of a high
percentage of opaque variants (Table 1). This result demonstrates
that the sessile opaque pneumococci have more ability to
disseminate into internal host tissues than their planktonic
counterpart. Alternatively, sessile opaque pneumococci most
probably have a greater ability to resist phagocytosis than their
transparent counterpart. Indeed, this would be expected as it has
Figure 2. SEM analysis showing: (A), the presence of matrix in the planktonic culture of low biofilm-forming bacteria (WCH43), and
(B) the presence of matrix in the sessile culture of high biofilm-forming bacteria (WCH159).
doi:10.1371/journal.pone.0019844.g002
Figure 1. Abilities of various pneumococcal strains to establish biofilm in a static biofilm assay. (A), WCH158, WCH159 and D39 were
able to form stable biofilm over the incubation period (peaking at day 4), whereas WCH16, WCH43 and WCH132 were impaired in their abilities to
form biofilms (P=0.005 and P=0.002 at days 4 and 5, respectively; Students t-test; two-tailed). Data for each time point are means 6 SEM triplicate
samples from a combination of three experiments. (B–G), SEM analysis showing bacteria attached to the surface in samples of low-biofilm-forming
pneumococci, but without matrix (B–D); and the presence of matrix in samples of high-biofilm-forming pneumococci (E–G).
doi:10.1371/journal.pone.0019844.g001
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capsule than their transparent counterpart [15].
Adherence to A549 and Detroit 562 cell lines by biofilm-
forming opaque bacteria
The animal infection experiments described above show that
the sessile opaque variant of WCH159 could translocate to the
lungs and brain of infected mice, whereas planktonic organisms
could not. To complement the in vivo findings, we investigated
whether the matrix produced by sessile opaque bacteria could also
promote bacterial adherence to A549 human lung cell monolay-
ers. For this assay, the same planktonic and sessile cultures of
transparent and opaque WCH159 grown for the animal challenge
experiments were used. As shown in Fig. 5A, the matrix-producing
sessile opaque bacteria were able to adhere to the A549 cells
.10
2-fold more than all the others cultures tested. To determine
whether this was a general phenomenon, we performed the same
experiment using a human pharyngeal epithelial cell line (Detroit
562). Interestingly, no difference in adherence was observed
between any of the cultures (Fig. 5B). It is known that S. pneumoniae
engages a number of cell surface molecules as targets for diverse
adhesins. For example, CbpA binds to polymeric immunoglobulin
receptor (pIgR) [34], while phosphoryl choline moieties on
teichoic acid recognise the platelet activating factor (PAF) receptor
[35]. There are marked differences in the relative expression of
these host receptors between cell lines, with Detroit 562
(nasopharyngeal) cells expressing higher levels of pIgR than
A549 (type II pneumocyte) cells, while the reverse is true for the
PAF receptor [34,35]. Thus, these data suggests that the matrix-
producing sessile opaque bacteria may exhibit a phenomenon
specific to some experimental models or cell types.
Gene expression analysis
To identify the genes responsible for the in vitro and in vivo
phenomena described above, we cross-compared RNA prepara-
tions from sessile and/or planktonic cultures from transparent
and/or opaque bacteria by microarray analysis. Fully annotated
microarray data have been deposited in BmG@Sbase (accession
number E-BUGS-117; http://bugs.sgul.ac.uk/E-BUGS-117) and
also ArrayExpress (accession number E-BUGS-117). Very few
genes were significantly differentially expressed in all combina-
tions analyzed, and this was confirmed by real time RT-PCR
(Table 2). In particular, two genes (ciaR and ciaH)w e r e
differentially expressed between sessile and planktonic opaque
variants. These genes form part of the same operon, the two
component system 5 (TCS05) [36], which had been found to be
involved in colonization and adherence in mouse and rat models
[37,38].
Another comparison that produced an interesting differential
gene expression pattern was the sessile transparent versus sessile
opaque. In all experiments, the lic operon was consistently
significantly differentially expressed, being upregulated in the
sessile opaque variants. It is already known for other respiratory
pathogens such as H. influenzae and N. meningitidis that the lic
operon (involved in choline uptake and metabolism) is positively
associated with biofilm formation [39,40,41]. It has been shown
that viable mutants of this operon can only be obtained in the
licD2 gene, which is required for phosphorylcholine (P-cho)
incorporation into lipoteichoic acid [42]. Accordingly, we
constructed in-frame mutants of ciaRH and licD2 to investigate
whether the respective mutations can affect adherence and matrix
formation.
Biofilm characteristics of ciaRH and licD2 mutants
The impact of mutating ciaRH and licD2 was assessed in a static
biofilm assay, essentially as described above for wild type bacteria.
The numbers of bacteria recovered from pure transparent and
opaque biofilms was consistently approximately 100-fold less than
what was obtained from mixed culture biofilms. This presumably
indicates that the presence of both variants is necessary to achieve
high cell density of adherent bacteria. Surprisingly the DciaRH
mutant showed a different behaviour depending on the phenotype
analyzed. As shown in Fig. 6A, the transparent variant of the
DciaRH mutant was able to form biofilm to the same level as the
wild type, over 5 days. However, for the opaque DciaRH mutant,
only 10
2 bacteria could be recovered after 3–5 days incubation
suggesting that a different regulation occurs between the two
phenotypic variants. In contrast, the DlicD2 mutant showed a
significantly lower level of biofilm with respect to the wild type in
variants of both phenotypes (P,0.01 on days 4 and 5). Similar
results were obtained using DciaRH and DlicD2 mutants in D39
background, as shown in Fig. 6B. SEM analysis of DciaRH and
Figure 3. SEM analysis showing: (A), biofilm opaque WCH159 completely embedded in an extracellular matrix and (B), only pure
bacteria (no matrix) in the biofilm transparent counterpart.
doi:10.1371/journal.pone.0019844.g003
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mutants (Fig. 6C and D).
Adherence of ciaRH and licD2 mutants to A549 cells
Wild type and DciaRH or DlicD2 mutants from opaque and
transparent biofilm cultures were tested for adherence to A549
cells. For opaque biofilm-derived bacteria, the adherence of the
DlicD2 and DciaRH mutants was 10
2-10
3-fold lower than that of
the strongly adherent wild type. In contrast, for transparent phase
bacteria, the wild type and DlicD2 and DciaRH mutants all
exhibited similarly low adherence (Fig. 7A). Similar results were
obtained using isogenic mutants of D39 on A549 cells (Fig. 7B).
However, the opaque wild type D39 strain adhered to Detroit 562
cells significantly better than the opaque WCH159 strain (Fig. 7C).
This could probably be due to the different biofilm architectures,
which may be strain-dependent. Alternatively, WCH159 might
lack an adhesin that could be present on the surface of D39 cells.
SEM analysis of WCH159 adherence to A549 cells showed
presence of extracellular matrix and strong attachment of wild
type opaque biofilm bacteria (Fig. 7D). However, no matrix could
be seen on A549 cells infected with transparent sessile bacteria
(Fig. 7E).
In vivo characteristics of DciaRH and DlicD2 mutants
In order to assess the effects of mutating ciaRH and licD2 on the
ability of the biofilm-forming opaque variant to invade the lungs
and brain, CD1 mice were challenged with the mutants recovered
from static biofilm cultures. The corresponding wild-type biofilm-
forming opaque bacteria served as a control. As shown in Fig. 8,
there was no significant difference in colonization in nasopharyn-
geal colonization between all groups, except between transparent
DciaRH mutant vs opaque DciaRH mutant (P=0.02). As observed
in the earlier experiment with wild type bacteria, no bacteria were
detected in the blood of mice at any time point in this experiment
(not shown). As expected, nasopharyngeal colonization by wild
type transparent and opaque bacteria was essentially the same
level at 24 h and at day 4. The level of colonization of the
nasopharynx by the transparent DciaRH mutant was also
comparable to that of the wild type. However, both phenotypes
of the DlicD2 mutant were significantly attenuated for nasopha-
ryngeal colonization with respect to the respective wild type
counterpart (P,0.001 in both cases). In addition, the capacities of
the opaque phenotypes of both mutants to translocate to the lungs
and brain were completely abolished at day 4 (P=0.003), although
the difference was not statistically significant in the brain.
Characterization of the extracellular matrix
To further characterize the nature of the extracellular matrix
produced by the opaque variant, all samples grown in the static
biofilm model were electrophoresed on SDS-PAGE and immuno-
blotted with TEPC-15 (a mouse anti- P-cho monoclonal antibody).
As shown in Fig. 9, we detected more choline associated with
teichoic acid (TA) in opaque sessile samples, and it was completely
absent in the two mutants. This result is in accordance with licD2
upregulation, and indicates that TA might be part of the
extracellular matrix. Furthermore, the differential centrifugation
showed that the supernatant fractionis composed almost exclusively
of the matrix, because it was devoid of bacteria upon subsequent
plating on blood agar (Figure S3). As shown, addition of proteinase
K treatment to the samples resulted in partial loss of the band
intensity. DNase and proteinase K treatment of samples from
WCH159and D39 also resulted inpartial degradation ofthe matrix
(result not shown). Congo red staining of cultures also showed
colour change from red to pink-orange for the sessile opaque strains
(not shown). These results suggest that the matrix formed by these
strains is similar to that described by others [6,43,44].
Capsule ELISA
To determine whether some of the differences observed
between the strains are related to changes in capsule regulation
Table 1. Relative percentages of opaque and transparent colonies from bacteria harvested in vivo.
Strain Percentage of opaque phenotype in various niches at the indicated time points:
a
Nasopharynx Lungs Brain
24 h 96 h 24 h 96 h 24 h 96 h
Wt Opaque 90 85 90 100 -
b 96
Wt Transparent 35 25 75 - 75 -
DciaRH O p a q u e1 0 0 1 0 0 ----
DciaRH T r a n s p a r e n t 3 7 4 8 ----
DlicD2 O p a q u e 8 5 9 7 ----
DlicD2 Transparent 25 45 ----
aData were obtained by plating bacteria harvested from the indicated niches on THY-catalase plates.
bindicates no bacteria were detected.
doi:10.1371/journal.pone.0019844.t001
Figure 4. Mouse intranasal (i.n.) infection model. Groups of mice were infected i.n. under anesthesia with the indicated variants of WCH159. At
24 h post-infection, transparent variants adhered to the nasopharynx strongly and at comparable levels, but significantly better than their opaque
counterparts (* P=0.03 in both cases). At 48 h, the planktonic and sessile transparent bacteria adhered significantly better to the nasopharynx than
the planktonic opaque bacteria (* P=0.048; Students t-test; two-tailed). There was a 10-fold increase in the level of nasopharyngeal colonization of
mice infected with the transparent phenotype at 4 days post-infection; this difference was not statistically significant between planktonic and sessile
forms of the opaque variant. In the lungs and brain, bacteria could only be recovered from mice infected with sessile opaque culture by day 4
(*** P=0.0002; Students t-test; two-tailed). Solid horizontal line is median for 9–10 mice per tissue at the indicated time post-infection. Dotted lines
represent limit of detection (40 CFU).
doi:10.1371/journal.pone.0019844.g004
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WCH159 and their isogenic mutant derivatives. Our measure-
ments show that total amount of capsule in all the strains are
essentially similar (approx. 10 ng total capsule/ 10
9 cells).
Discussion
Despite the many studies on biofilm formation in S. pneumoniae,i t
is still not completely clear why some serotypes are more likely to
form a biofilm in vitro or in vivo, or whether a correlation exists
between biofilm formation in vitro and ability to cause invasive
disease [28,29]. Some lines of evidence have demonstrated that S.
pneumoniae can form biofilms in vivo and are able to form a sticky
matrix on the mucosal surface, although not all pneumococcal
serotypes are able to invade the host and cause disease [6,45]. By
starting with pure cultures of opaque and transparent phenotypes,
we have demonstrated that the ability to form matrix is an
exclusive feature of the opaque variant and that this phenomenon
shows strain-specific variations. Static biofilm assays carried out on
transparent and opaque variants of pneumococci allowed us to
separate strains into low and high biofilm formers, with a high
proportion of transparent variants in the low biofilm-forming
group. The transparent variants of some strains failed to form a
biofilm after 2 days incubation, whereas the opaque variants of all
the strains were able to remain attached to the plastic surfaces up
to 5 days. Our results suggest that the opaque phenotype seems to
be indispensable to maintaining bacterial aggregation and
attachment to the surface. The explanation for this phenomenon
was found when sessile and planktonic bacteria of transparent or
opaque phenotypes were analyzed by SEM. Surprisingly, we
found the presence of abundant extracellular matrices only in the
opaque, sessile samples, whereas the transparent variants were
unable to build an extracellular matrix in any of serotypes tested.
Biofilm has been reported to be involved in the pathogenesis of
other bacterial diseases. For example, in P. aeruginosa, a Gram-
negative pathogen responsible for a wide range of infections
including lung infection in cystic fibrosis patients, biofilm and
consequent production of matrix is the major virulence factor [46].
In oral streptococci, the extracellular matrix is directly involved in
adherence to dental surfaces during the development of dental
caries [47,48]. Furthermore, Staphylococcus aureus, which is respon-
sible for frequent catheter- or prosthesis- derived infections, is
extremely difficult to treat due to the matrix which it is able to
build [49,50]. Finally, H. influenzae, which also causes pneumonia,
meningitis and OM, shares many aspects of biofilm formation and
extracellular matrix production as pneumococci [51,52].
To investigate how the bacteria embedded in an extracellular
matrix are involved in the pathogenesis of pneumococcal disease,
we infected mice with bacteria collected from sessile and
planktonic morphs of transparent and opaque variants [32]. Only
groups of mice infected with opaque sessile pneumococci showed
infection of the lungs (and brain) at 4 days post-infection, and these
findings were supported by A549 adherence assay. In fact, A549
cells infected with opaque and transparent planktonic bacteria
showed no difference in adherence. This is in agreement with
another study, which showed that planktonic opaque and
transparent pneumococcal variants adhered to a similar degree
to non-activated epithelial and endothelial cells [53]. In contrast,
sessile opaque bacteria adhered 1000-fold more to the A549 cells
than all the other samples, suggesting a role for the matrix in the
process. Our findings showing stronger binding of opaque biofilm-
derived bacteria to A549 cells (but not to Detroit 562 cells) is as
expected, given that the biofilm-associated matrix contains a large
amount of TA, thereby promoting strong interaction with the PAF
Figure 5. Adherence to A549 and Detroit 562 cells. Planktonic and
sessile cultures of transparent and opaque WCH159 grown in a static
biofilm model for 4 days, were used in these assays. (A), the matrix-
producing sessile opaque bacteria were able to adhere to A549 cells
at greater than 10
2-fold more than all the others samples tested
(*** P=0.001; Students t-test; two-tailed). (B), no difference in adherence
to Detroit 562 cells between all samples tested. The experiment was
performed four times, with similar results. Data are means 6 SEM of
quadruplicate samples from a combination of three experiments.
doi:10.1371/journal.pone.0019844.g005
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adherence to lung cells is consistent with progression to invasive
disease. Likewise, the lack of a statistically significant difference in
longer-term nasopharyngeal colonization is consistent with the
Detroit 562 adherence data.
In our attempt to understand the molecular basis for the
observed phenomenon, we used microarray analysis to investigate
the gene expression profiles of planktonic and sessile bacteria from
transparent and opaque variants. The analysis showed regulation
principally in two operons: the lic operon, which is involved in
choline uptake, and the ciaRH operon, the first two-component
system to be characterized in S. pneumoniae [36]. The lic operon
plays a key role in the survival of pneumococci, as a deletion in this
operon is lethal [54]. Choline is taken up from medium and
transported inside of the cell by Lic1, converted to P-cho, and then
incorporated into the TA chains by licD2 [42]. P-cho occurs as
cell-wall-associated and lipotheichoic acid, and is a surface
component of many mucosal pathogens, such as Neisseria and H.
influenzae. These bacteria reside in the same biological niche and
share an identical gene set for choline uptake and incorporation
(licA–D). In these bacteria, lic expression correlates positively with
biofilm maturation [39,41,55,56]. In this study, the operon was
highly up-regulated in bacteria collected from opaque samples
consisting of more complex attached microbial communities.
Upregulation of the operon was further confirmed by RT-PCR
analysis of licA and tacF (Table S1), which showed upregulation of
both genes in the sessile opaque bacteria (as seen with the
expression of licD2). These results are consistent with findings in
other mucosal pathogens such as Neisseria and H. influenzae. We also
determined relative expression of choline binding proteins (CBPs)
cbpA, lytA, pcpA, and pspA between RNA samples from sessile
opaque and sessile transparent bacteria. Interestingly, the
expression of all these genes was much higher in RNA samples
from the sessile transparent bacteria (Table S1).
To further investigate the role of the lic operon in pneumococcal
biofilm formation and pathogenesis, we constructed a DlicD2
mutant, this being the only gene in the lic operon that is not lethal,
and results in a decrease, but not total abolition of choline uptake
[42]. The mutant was unable to form a stable biofilm in both
transparent and opaque variants; both variants were also impaired
in nasopharyngeal colonization and ability to translocate to the
lungs or brain at all time points. In addition, the level of adherence
of the opaque DlicD2 mutants to A549 cells was massively
diminished relative to the opaque wild type, and comparable to
that of the transparent wild type variant. Interestingly, it was
reported that the lic operon was upregulated in CSF cultures and
in pneumococci adherent to epithelial cells, and there was an
enhanced expression of the ciaR/H genes during endothelial cell
contact [57].
The in vitro and in vivo effects of licD2 mutation observed here
correlate with those seen with licD2 mutants of non-typeable H.
influenzae [4,39]. Decrease in ability to incorporate P-cho into the
TA chains correlates with inhibition of matrix formation,
capacity of cause invasive disease as well as adhere to lung cells.
Furthermore, the ciaRH operon was more highly expressed in
opaque sessile bacteria compared to their planktonic counterpart.
The ciaRH two-component system has previously been found to
be the only two-component system in S. pneumoniae that is
positively involved in colonization and related to biofilm [36,38].
In our static biofilm model, the opaque ciaRH mutant was unable
to maintain a stable biofilm beyond two days, whereas the
transparent counterpart showed the same level of biofilm as the
wild type, up to five days. In the mouse model, colonization of the
nasopharynx by the transparent ciaRH mutant was comparable to
wild type levels, while the opaque ciaRH mutant was unable to
colonize the nasal tissue beyond 24 h. Essentially similar results
were obtained in the A549 adherence assay. Since it is already
known that ciaRH positively regulates the expression of htrA [37],
we investigated the expression of this gene by real time RT-PCR.
Our data shows that there was a concomitant increase in htrA
expression in opaque sessile sample, where the expression level of
ciaRH was also upregulated. However, these findings contrast
with a recent report of the phenotypic effect of ciaRH mutation on
expression of htrA in transparent and opaque variants [58]. In
that study, transcriptional analysis of htrA levels in opacity
variants demonstrated that transparent strains produce more htrA
Table 2. Microarray comparisons of gene expression of S. pneumoniae WCH159 transparent (T)/opaque (O) and sessile (S)/
planktonic (P) variants.
Gene ID (TIGR4)
a Gene ID (G54)
b Gene annotation Fold Change
SO/ST PO/PT SO/PO ST/PT
SP_1274 SPG_1168 LicD2 protein 7.6 (100.0)
c 5.6 (28.6) (22.0) 6.2 (1.7)
SP_2108 SPG_2045 Maltose/maltodextrin ABC transporter (59.0) 7.6 (29.6) (0.4) (249.7)
SP_1580 SPG_1505 Sugar ABC transporter, ATP-binding protein;
maltose/maltodextrin transport system ATP-binding
24.6 (213.8) 5.3 (9.3) (24.1) (1.0)
SP_0061 SPG_0065 PTS system, IIB component; K02794 PTS system,
mannose-specific IIB component
28.4 (210.8) (10.3) (1.6) 28.3 (23.8)
SP_0083 SPG_0084 Two-component system, OmpR family, response
regulator
27.3 (217.1) (5.2) -
d (21.8)
SP_2148 SPG_2088 Arginine deiminase 24.3 (213.0) (6.3) (21.5) (1.7)
SP_0798 SPG_0728 Two component System 05 Response Regulator (CiaR) - - 5.5 (19) -
SP_0799 SPG_0729 Two component System 05 Histidine Kinase (CiaH) 5.96
SP_2239 SPG_2188 Serine protease HtrA - - (11.4) (1.06)
a, bGene IDs were obtained from the S. pneumoniae TIGR4 (serotype 4) and G54 (serotype 19F) genomes as deposited in the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database.
cData in parentheses represent corresponding real time RT-PCR values for the indicated genes.
dNo difference in gene expression was observed.
doi:10.1371/journal.pone.0019844.t002
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This discrepancy could be due to the fact that in our study,
analysis was carried out on bacteria collected from a 4-day old
biofilm assay rather than from bacteria grown in rich broth to
late exponential phase. Consistent with this, we found by RT-
PCR analysis that htrA expression in late exponential phase
cultures of transparent bacteria was higher than in opaque
bacteria (Table S1).
In S. pneumoniae, ciaRH has been shown to positively regulate
expression of the lic operon [37] which is responsible for P-cho
uptake and incorporation onto TA. Choline has been shown to be
present in pneumococcal biofilm matrix [43]. Thus, it may be
expected that the molecular mechanism behind the opaque
associated-matrix phenomena is related to increased ability of
opaque variants to process choline through the lic system. Choline
is needed for many physiological functions in the human body
Figure 6. Biofilm and in vitro adherence characteristics of DciaRH and DlicD2 mutants of WCH159 and D39. (A), Static biofilm assay
performed with WCH159 derivatives showing that the transparent variant of the DciaRH mutant was able to form biofilm to the same level as the wild
type, over 5 days, whereas the opaque DciaRH mutant could not. However, the DlicD2 mutant showed a significantly low level of biofilm with respect
to the wild-type in both phenotypes (* P=0.01 on days 4 and 5; Students t-test; two-tailed). Data for each time point are means 6 SEM quadruplicate
samples. (B), Static biofilm assay performed with D39 derivatives; data for each time point are means 6 SEM quadruplicate samples. (C and D); SEM
analysis showing only pure bacteria (no matrix) in the DciaRH and DlicD2 mutants, respectively.
doi:10.1371/journal.pone.0019844.g006
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between cells, but most importantly, plays a key role in the brain.
It is a precursor for acetylcholine and membrane phosphatidyl-
choline, and is obtained principally by dietary intake and
transported across the blood-brain barrier through facilited
diffusions [59,60]. Meningitis-associated and biofilm-forming
pathogens such as N. meningitidis, H. influenzae and S. pneumoniae
are able to take up choline and then process and display it on the
surface. The importance of surface display of choline residues on
the surface of H. influenzae is well characterized [61]. By using
novel fluorescent reporter systems, membrane localization of
choline-utilization (Lic) proteins in S. pneumoniae was demonstrated
[62]. Studies on the role of choline in S. pneumoniae have found the
lic operon to be highly expressed in adherence, biofilm and brain
infection [38,57]. However, a direct link between matrix forming-
opaque phenotype and lic operon was not explored. In this paper,
we showed the important role for choline in biofilm formation and
in vivo infection by S. pneumoniae.
Our data could also explain the role of the transparent and
opaque variants in the disease process. We hypothesize that the
transparent phenotype is recovered more frequently from the nasal
surface than the opaque counterpart at least in part because it is
unable to form a matrix. We also hypothesize that matrix
production is not capsule-dependent because it has been shown
that rough strains are still capable of forming a sticky matrix in a
biofilm assay [6]. This hypothesis is further supported by our
finding that total CPS produced by the WCH159 strains and their
isogenic mutant derivatives were essentially similar. On the other
hand, the sticky matrix produced by the opaque variant facilitates
attachment to the mucosal surface, protects from attack by the
immune system, and allows translocation to deeper host tissues.
The preference for some strains to be in the transparent phase
rather than opaque could be also the reason why some strains can
invade the host while others cannot.
Recently, it was shown that early biofilm formation on
microtiter plates does not correlate with the invasive disease
potential of S. pneumoniae [63]. That study was performed using
18 h-old biofilms, where the bacteria had probably not produced
an extracellular matrix. However, our study demonstrates that
opaque pneumococci that produce extracellular matrix from a 4-
day old biofilm culture are more capable of causing invasive
disease. Thus, these differences could account for the discrepancy
between the two studies. Our data also indicate that only the
opaque phenotype is able to form extracellular matrix, and that
the lic operon and ciaRH contribute to this process. We believe that
the opaque variant is more capable of taking up choline from the
environment due to the high expression of the lic operon, and this
substance is then used in the formation of matrix.
These data have provided new insights into the molecular basis
and significance of biofilm formation by S. pneumoniae and by
pathogenic bacteria in general. This study has also increased our
understanding of bacterial pathogenesis and opens a new vista to
the development of alternative prophylactic and/or therapeutic
strategies by targeting the extracellular matrix produced by
pathogenic bacteria.
Materials and Methods
Ethics Statement
This study was conducted in compliance with the Australian
code of practice for the care and use of animals for scientific
purposes (7th Edition 2004) and the South Australian Animal
Welfare Act 1985. All animal experiments were approved by the
Animal Ethics Committee of the University of Adelaide (Project
Number: S-86-2006).
Bacterial strains and growth conditions
S. pneumoniaestrains used in this study are listed in Table3. Bacteria
were sub-cultured from a frozen stock culture onto Todd-Hewitt agar
supplemented with 0.5% yeast extract (THY agar) and 5,000 U of
catalase, and incubated at 37uC in 95% air, 5% CO2 overnight.
Colony morphology of variants on THY-catalase plates was
determined under oblique transmitted illumination as previously
described [14]. Pure cultures of the two variants selected on THY-
catalase plates were subcultured three consecutive times, and
remained stable upon subculturing. A single colony of each
phenotype variant was then used to inoculate 5 ml of THY broth
and incubated at 37uC in 95% air, 5% CO2.T h ec u l t u r e sw e r e
grown until the mid-logarithmic phase (A590=0.2) in THY broth
without catalase and used to inoculate the microtiter plates for biofilm
formation assay. Before the assays, the growth rates of all strains were
determined and these were essentially similar (not shown).
Biofilm assays
Static biofilm assay was performed by growing bacteria in 96-
well flat-bottom polystyrene plates (Sarstedt). Approximately
1610
5 mid-exponential phase pneumococci were inoculated
1:10 into 1:3 diluted THY medium. The plates were incubated
at 37uCi naC O 2-enriched atmosphere for 1, 2, 3, 4 or 5 days. To
permit the extension of the experiment for days, medium was
changed daily. To collect bacteria attached to the plastic
substratum, plates were washed 3 times and filled with 100 mlo f
fresh THY medium, sealed and floated on a sonicating water bath
(Transonic 460/H ultrasonic bath) and sonicated for 3 sec at
35 KHz. To evaluate and quantify the colony morphology
variants, planktonic and sessile cultures were harvested at various
time points, serially diluted, and plated onto THY-catalase plates.
At each time point, bacterial morphology and formation of
aggregates was checked by light microscopy. As already reported
[33], the time of sonication was enough to disperse bacterial
aggregates. At 4 days post incubation, biofilm was used for mouse
challenge experiments, RNA extraction, and adherence assays.
Bacteria were harvested from the planktonic phase and then from
the bottom of microtiter plates by sonication. All types of inocula
were resuspended in THY, stored as frozen aliquots, and diluted in
THY for challenge and adherence assays. For RNA extraction,
samples were immediately processed after collection.
Scanning electron microscopy (SEM)
SEM was performed on 4 day biofilms formed on plastic
coverslips (0.2 mm thick, 13 mm diameter; Nunc) in 24-well
Figure 7. Biofilm and in vitro adherence characteristics of DciaRH and DlicD2 mutants of WCH159 and D39. (A), Experiments performed
in WCH159 background; only the matrix-producing opaque wild-type bacteria were able to adhere to A549 cells at greater than 10
2-fold more than
all the others samples tested (*** P=0.003; Students t-test; two-tailed). (B), Experiments performed in D39 background; only the matrix-producing
opaque wild-type bacteria were able to adhere to A549 cells (B) and Detroit 562 cells (C) at greater than 10
2-fold more than all the others samples
tested (** P=0.003; Students t-test; two-tailed). Each adherence assay was performed three times, with similar results. Data are means 6 SEM of
triplicate samples from a typical experiment. (D), SEM showing presence of extracellular matrix and strong attachment of wild-type opaque biofilm
bacteria to the surfaces of A549 cells (indicated by arrows). (E), No matrix could be seen on A549 cells infected with transparent sessile bacteria.
Arrows indicate bacteria only.
doi:10.1371/journal.pone.0019844.g007
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Plates were statically incubated at 37uC for 4 days and media
changed daily, as described above. At the end of the incubation,
the coverslips were washed with phosphate-buffered saline (PBS),
and fixed O/N at 4uC with a solution of 3% gluteraldehyde
(Sigma). The coverslips were washed three times with PBS, 4%
sucrose, and post-fixed with 0.1% osmium tetraoxide for 1 h. After
3 washes in the same buffer, a series of dehydration steps was
performed using graded ethanol baths (70%, 90% and 100%,
three times for 10 min each). After critical point drying and
coating by gold sputter, samples were examined with a Philips
XL30 FEGSEM scanning electron microscope. For each exper-
iment, 3 replicates resulting from 3 independent inocula were
analyzed.
Adherence assays
A549 human lung alveolar carcinoma (type II pneumocyte) and
nasopharyngeal human carcinoma epithelial (Detroit 562) cell
lines were used for adherence assays. Cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) and Minimal
essential medium with Earle’s salt (EMEM), respectively, and
supplemented with 10% fetal calf serum (FCS) and maintained in
the appropriate medium with 1% FCS. Cells were grown in 75-
cm
2 tissue culture bottles (Becton Dickinson) at 37uC in a 5% CO2
atmosphere. Confluent cells were seeded into 6-well tissue culture
trays (Becton Dickinson) for use in the adherence assays. Opaque
and transparent variants of strain WCH159 were grown in a static
biofilm assay and used for adherence assays. Cultures were diluted
to the appropriate density (5610
6 CFU/ml) in DMEM or EMEM
plus 10% FCS (without antibiotics) and 1 ml aliquots were
inoculated onto washed A549 or Detroit 562 cells. After
incubation for 2 h at 37uC, the wells were washed three times
with PBS and cells were detached from the plate by treatment with
100 ml of 0.25% trypsin-0.02% EDTA. Appropriate dilutions of
the cultures were plated on blood agar to determine the number of
adherent bacteria. Assays were performed in quadruplicate from
four independent experiments. For scanning electron microscopy,
tissue cultures infected with the same bacteria were grown on
coverslips and treated as described above.
Intranasal challenge of mice
Groups of either 15 or 30 female CD-1 mice (5–6 weeks old)
were anesthetized by intraperitoneal injection of sodium pento-
barbitone (Nembutal; Rhone-Merieux) at a dose of 66 mg per g of
body weight and challenged intranasally with 50 ml of bacterial
suspension containing approximately 5610
6 CFU in THY
medium. The challenge dose was confirmed by plating serial
dilutions of the inocula on blood agar. At 24, 48 and 96 h post
challenge, 5 or 10 mice infected with each strain were euthanased
by CO2 asphyxiation, and nasal wash, nasal tissue, lung, blood and
brain samples were plated on blood agar to enumerate
pneumococci present in each niche and on THY+catalase plates
to check colony morphology, as described previously [64]. The
Ethics Committee of The University of Adelaide approved all
animal experiments.
RNA extraction and microarray analysis
RNA was isolated from biofilm samples by using acid-phenol-
chloroform-isoamyl alcohol (125:24:1 pH 4.5; Ambion) and
treated as described previously [64,65]. Microarray experiments
were performed on whole genome S. pneumoniae PCR arrays based
on TIGR4 and R6 annotations [66]. Array slides were obtained
from the Bacterial Microarray Group at St George’s, University of
London. The array design is available in BmG@Sbase (Accession
No. A-BUGS-14; http://bugs.sgul.ac.uk/A-BUGS-14) and also
ArrayExpress (Accession No. A-BUGS-14).
Fluorescently labelled cDNAs were hybridized to the surface of
the microarray as described previously [67,68]. The Spot plugin
(CSIRO, Australia) within the R statistical software package
(http://www.R-project.org) and the Limma plugin for R [69]
were used for data processing and statistical analysis. Ratio values
were normalized using the print-tip Loess normalization routine
[70] and a linear model fitted to determine a final expression value
for each mRNA [71]. These statistics were used to rank the
mRNAs from those most likely to be differentially expressed to the
least likely using false discovery rate of P,0.05. A fold change of
$2.0 in gene expression with statistical significance (P#0.01) was
classified as being significantly changed. In this study, nine
independent hybridizations, including one labelled by dye reversal,
using RNA samples isolated from four separate assays were
performed for each incubation time point.
Real-time RT-PCR
For a subset of selected genes, differences in levels of expression
obtained by microarray analysis were validated by one-step
relative quantitative real time RT-PCR in a Roche LC480 Real-
Time Cycler, essentially as described previously [67]. The specific
primers used for the various RT-PCR assays are listed in Table S2
and were used at a final concentration of 200 nM per reaction. As
Figure 9. Western blotting of supernatant and pellet (approx 5
610
6 CFU/ml) fractions of samples from a 4-day static biofilm
cultures of transparent and opaque WCH159 with TEPC-15 (a
mouse anti-phosphorylcholine monoclonal antibody). Lanes: 1,
Sessile opaque bacteria; 2, Sessile opaque bacteria, proteinase K-treated
for 3 h; 3, Sessile transparent bacteria; 4, Sessile opaque, DlicD2 mutant
bacteria; 5, Sessile transparent, DlicD2 mutant bacteria; 6, Sessile
opaque bacteria, proteinase K-treated for 1 h; 7, Sessile opaque, DciaRH
mutant bacteria; 8, Sessile transparent, DciaRH mutant bacteria; 9, liquid
opaque bacteria; 10, liquid transparent bacteria.
doi:10.1371/journal.pone.0019844.g009
Figure 8. Mouse i.n. infection model showing the effects of ciaRH and licD2 mutation on their abilities to cause invasive disease.
Groups of mice were infected i.n. under anesthesia either with wild-type WCH159 or its otherwise isogenic DciaRH or DlicD2 mutant. As shown, with
the exception of the opaque DciaRH mutant, no significant difference in the colonization of the nasopharynx could be detected at 24 h in all groups
tested. However, both phenotypes of the DlicD2 mutant were severely impaired for colonization of the nasopharynx (** P,0.001; Students t-test;
two-tailed). The opaque phenotypes of both mutants were also unable to translocate to the lungs (** P=0.003; Students t-test; two-tailed) or the
brain (not statistically significant) at 4 days post-infection. Solid horizontal line is median for 5 mice per tissue at the indicated time post-infection.
Dotted lines represent limit of detection (40 CFU).
doi:10.1371/journal.pone.0019844.g008
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employed. Amplification data were analyzed using the compara-
tive critical threshold (2
-DDCT) method [72].
Mutant construction and transformation
Mutants were constructed by gene SOEing essentially as
described previously [73,74]. Deletion of licD2 and the ciaRH
operon was achieved by replacing the respective genes in
WCH159, in-frame, with a spectinomycin- or erythromycin-
resistance cassette, respectively. The primers used are listed in
Table 4. Opaque and transparent bacteria were transformed using
competence stimulating peptide (CSP)-1 or 2, essentially as
described previously [74]. Mutants were selected by multilayer
plating as previously described and verified by sequencing using
primers flanking the gene in question [74].
Multi-locus sequence typing (MLST)
For MLST analysis, the aroE, gdh, gki, recP, spi, xpt, and ddl genes
for the S. pneumoniae strains were PCR-amplified and sequenced.
The sequence type (ST) of strains was obtained from the MLST
database (http://www.mlst.net) based on the resulting allelic
profiles.
Western blotting
All cultures of transparent and opaque WCH159 grown in the
4-day static biofilm model were analyzed for the presence of TA
by Western blotting with TEPC-15 (a mouse anti-P-cho
monoclonal antibody). Prior to SDS-PAGE and immunoblotting,
samples were placed in 2 ml vials containing 2.8 mm ceramic
beads and pulsed in a Precellys 24 tissue homogeniser (Bertin
Technologies) at 3 cycles of 30 seconds at 5000 rpm to disperse
any bacteria that might be embedded in the matrix. Samples
(containing approx 5610
6 CFU/ml bacteria) were then centri-
fuged at 18,0006g for 3 min to pellet the bacteria, and aliqouts of
the supernatant fractions of sessile opaque samples subjected to
proteinase K treatment. The supernatant and pellet fractions were
then resuspended in sample loading buffer, electrophoresed,
transferred unto nitrocellulose and blotted with TEPC-15. The
secondary antibody was goat-anti mouse IgA conjugated to
alkaline phosphatase (Zymed laboratories, San Francisco, CA,
USA).
ELISA for CPS quantitation
Total CPS produced by WCH159 strains and their isogenic
mutant derivatives was quantified by ELISA using a modification
of the method described previously [75]. Briefly, serial two-fold
dilutions of either purified type 19F CPS (American Type Culture
Collection, USA) standard (starting concentration of 10 mg/ml) or
total CPS preparations of bacteria [76] were coated unto poly-L-
lysine treated Nunc MaxiSorpH flat-bottom 96 well plates
Table 3. S. pneumoniae strains used in this study.
Strain Description Sequence type (ST)
a Source/Reference
D39 (O/T) Capsular serotype 2, opaque and transparent variants 595 [77]; This study
WCH16 Capsular serotype 6A clinical isolate 4966 Women’s and Children’s Hospital, North Adelaide, Australia
WCH43 Capsular serotype 4 clinical isolate 205 Women’s and Children’s Hospital, North Adelaide, Australia
WCH132 Capsular serotype 6B (L82016) 5400 D. E. Briles, UAB, Birmingham, AL, USA
WCH158 Capsular serotype 19F clinical isolate 1 Women’s and Children’s Hospital, North Adelaide, Australia
WCH159
(O/T)
Capsular serotype 19F clinical isolate, opaque and
transparent variants
1 Women’s and Children’s Hospital, North Adelaide, Australia;
This study
WCH159
DciaRH (O/T)
CiaRH in-frame deletion replacement mutant (Ery
R),
opaque and transparent variants
1 This study
WCH159
DlicD2( O / T )
LicD2 in-frame deletion replacement mutant (Spec
R),
opaque and transparent variants
1 This study
D39 DciaRH
(O/T)
CiaRH in-frame deletion replacement mutant (Ery
R),
opaque and transparent variants
595 This study
D39 DlicD2
(O/T)
LicD2 in-frame deletion replacement mutant (Spec
R),
opaque and transparent variants
595 This study
aThe sequence types of the strains was characterized as described in the Multi Locus Sequence Typing (MLST) database.
doi:10.1371/journal.pone.0019844.t003
Table 4. Primers used in this study.
Primer
a Sequence (59R39)
ciaRH Flank F ATGCACATGCTTCGCCGTTGGC
ciaRH Ery F TTGTTCATGTAATCACTCCTTCTATTAAAACTATT-
ATACCAAATTTGCC
ciaRH Ery R CGGGAGGAAATAATTCTATGAGTCCAACTGGGGCGA-
TATTTTGGAT
ciaRH Flank R GGGCCATTTGGCACCTGCAAAC
licD2 Flank F CTCGTCTCAGTTACTATCTGGGGA
licD2 Spec F TATGTATTCATATATATCCTCCTCTTTATAAGCGTGAAA-
TTCATGACTGTAG
licD2 Spec R AAATAACAGATTGAAGAAGGTATAATTGAGGGGGATT-
ATACAGACTAC
licD2 Flank R GACCATCCTTGGTACACAGGTTGC
JM214 GAGGAGTGATTACATGAAACAA
JM215 CTCATAGAATTATTTCCTCCC
JM253 GAGGAGGATATATATGAATACATACG
JM254 TTATACCTTCTTCAATCTGTTATTTAAATAGT-
TTATAGTTA
aPrimers for ciaRH and licD2 were derived from the S. pneumoniae G54
(serotype 19F) genome as deposited in the Kyoto Encyclopedia of Genes and
Genomes (KEGG) database.
doi:10.1371/journal.pone.0019844.t004
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samples were reacted with a 1:10,000 dilution of group 19 typing
sera (Statens Seruminstitut, Copenhagen, Denmark) for 4 h. The
plates were washed five times in wash buffer, and then reacted
with a 1:20,000 dilution of goat anti–rabbit IgG alkaline
phosphatase conjugate overnight at 4uC. After extensive washing,
the plates were developed using alkaline phosphatase substrate
(Sigma) in diethanolamine buffer, and read at A405 nm.
Statistical analyses
Unless where otherwise stated, statistical analyses for in vitro and
in vivo experiments were carried out using Student’s t-test, two-
tailed (GraphPad Prism version 5). A P value of ,0.05 was
considered significant.
Supporting Information
Figure S1 Colony morphology analysis of pneumococci on THY-
catalase plates after 4 day static biofilm assay, showing: (A)ah i g h
percentage of transparent variants (90%) in the low biofilm-forming
strains (WCH16, WCH43 and WCH132), and (B) a high percentage
(approx. 90%) of opaque variants (WCH158, WCH159 and D39) at
day 7.
(PDF)
Figure S2 Static biofilm assay of opaque and transparent
pneumococci. Opaque variants of D39, WCH43, WCH159,
WCH158, WCH132 and WCH16 were able to form stable biofilms
over the incubation period, peaking at day 4 (A), whereas the
transparent variants of D39, WCH16 and WCH43 were impaired in
their abilities to form biofilms (B).
(PDF)
Figure S3 Western blotting of supernatant and pellet fractions of
samples from a 4 days static biofilm cultures transparent and
opaque WCH159 with TEPC-15 (a mouse anti-phosphorylcholine
monoclonal antibody). Lanes: 1, liquid opaque bacteria; 2, liquid
transparent bacteria; 3, pellet fraction of sessile opaque bacterial
culture; 4, supernatant fraction of sessile opaque bacterial culture;
5, pellet fraction of sessile opaque bacterial culture; 6, supernatant
fraction of sessile opaque bacterial culture; 7, supernatant fraction
of sessile opaque bacterial culture, proteinase K-treated for 1 h.
(PDF)
Table S1 RT-PCR comparisons of gene expression of S.
pneumoniae WCH159 transparent (T)/opaque (O) and sessile (S)/
planktonic (P) variants.
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